Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2008 2
2009 2
2010 3
2011 7
2012 12
2013 15
2014 12
2015 12
2016 14
2017 10
2018 9
2019 11
2020 10
2021 14
2022 5
2023 9
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

132 results

Results by year

Filters applied: . Clear all
Page 1
Yeast Expression Systems: Overview and Recent Advances.
Baghban R, Farajnia S, Rajabibazl M, Ghasemi Y, Mafi A, Hoseinpoor R, Rahbarnia L, Aria M. Baghban R, et al. Among authors: farajnia s. Mol Biotechnol. 2019 May;61(5):365-384. doi: 10.1007/s12033-019-00164-8. Mol Biotechnol. 2019. PMID: 30805909 Review.
Antibody humanization methods - a review and update.
Safdari Y, Farajnia S, Asgharzadeh M, Khalili M. Safdari Y, et al. Among authors: farajnia s. Biotechnol Genet Eng Rev. 2013;29:175-86. doi: 10.1080/02648725.2013.801235. Epub 2013 Aug 2. Biotechnol Genet Eng Rev. 2013. PMID: 24568279 Review.
Antibody Based EpCAM Targeted Therapy of Cancer, Review and Update.
Eyvazi S, Farajnia S, Dastmalchi S, Kanipour F, Zarredar H, Bandehpour M. Eyvazi S, et al. Among authors: farajnia s. Curr Cancer Drug Targets. 2018;18(9):857-868. doi: 10.2174/1568009618666180102102311. Curr Cancer Drug Targets. 2018. PMID: 29295696 Review.
Anti-cancer Immunotoxins, Challenges, and Approaches.
Dashtiahangar M, Rahbarnia L, Farajnia S, Salmaninejad A, Shabgah AG, Ghasemali S. Dashtiahangar M, et al. Among authors: farajnia s. Curr Pharm Des. 2021;27(7):932-941. doi: 10.2174/1381612826666201006155346. Curr Pharm Des. 2021. PMID: 33023437
The Role of Interferons in Long Covid Infection.
Karbalaeimahdi M, Farajnia S, Bargahi N, Ghadiri-Moghaddam F, Rasouli Jazi HR, Bakhtiari N, Ghasemali S, Zarghami N. Karbalaeimahdi M, et al. Among authors: farajnia s. J Interferon Cytokine Res. 2023 Feb;43(2):65-76. doi: 10.1089/jir.2022.0193. J Interferon Cytokine Res. 2023. PMID: 36795973 Review.
Immunotoxins in cancer therapy: Review and update.
Akbari B, Farajnia S, Ahdi Khosroshahi S, Safari F, Yousefi M, Dariushnejad H, Rahbarnia L. Akbari B, et al. Among authors: farajnia s. Int Rev Immunol. 2017 Jul 4;36(4):207-219. doi: 10.1080/08830185.2017.1284211. Epub 2017 Mar 1. Int Rev Immunol. 2017. PMID: 28282218 Review.
Current trends in targeted therapy for drug-resistant infections.
Rahbarnia L, Farajnia S, Naghili B, Ahmadzadeh V, Veisi K, Baghban R, Toraby S. Rahbarnia L, et al. Among authors: farajnia s. Appl Microbiol Biotechnol. 2019 Oct;103(20):8301-8314. doi: 10.1007/s00253-019-10028-5. Epub 2019 Aug 14. Appl Microbiol Biotechnol. 2019. PMID: 31414162 Free PMC article. Review.
Evolution of phage display technology: from discovery to application.
Rahbarnia L, Farajnia S, Babaei H, Majidi J, Veisi K, Ahmadzadeh V, Akbari B. Rahbarnia L, et al. Among authors: farajnia s. J Drug Target. 2017 Mar;25(3):216-224. doi: 10.1080/1061186X.2016.1258570. Epub 2016 Nov 21. J Drug Target. 2017. PMID: 27819143 Review.
Development trends for generation of single-chain antibody fragments.
Farajnia S, Ahmadzadeh V, Tanomand A, Veisi K, Khosroshahi SA, Rahbarnia L. Farajnia S, et al. Immunopharmacol Immunotoxicol. 2014 Oct;36(5):297-308. doi: 10.3109/08923973.2014.945126. Epub 2014 Aug 1. Immunopharmacol Immunotoxicol. 2014. PMID: 25081575 Review.
132 results